Impact of lifestyle modifications on morbidities associated with polycystic ovarian syndrome
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20231912Keywords:
PCOS, Life style modificationAbstract
Background: The study aimed to systematically review the efficacy of long-term (6 to 9 months) lifestyle modifications in the form of dietary modifications, weight loss interventions, and psychosocial and behavioural changes.
Methods: This observational study was done on 110 women with PCOS-like features for one year. Personal and menstrual history was recorded. General and systemic examination was done. Routine investigations of blood and urine were done. The level of hormones was evaluated. USG of the lower abdomen and pelvis was also done. The data were recorded and analysed statistically.
Results: Significant difference was observed in all parameters before and after lifestyle and behavioral modifications.
Conclusions: Lifestyle interventions may improve weight and BMI in women with PCOS. Women who underwent lifestyle modifications significantly improved menstrual and reproductive function. We considered adopting a healthy lifestyle with a low-calorie diet and physical exercise that will generate weight loss.
References
Berek and Novak’s Gynaecology. Jonathan S. Berek.16th ed. Wolters Kluwer; 2020:896.
Jeffcoate's Principles of Gynaecology. Narendra Malhotra, Jaideep Malhotra, Richa Saxena, Neharika Malhotra Bora. 9th ed. JP Medical Ltd; 2018:460.
Rotterdam ESHRE/ASRM‐Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long‐term health risks related to polycystic ovary syndrome (PCOS). Human reproduction. 2004;19(1):41-7.
Shang Y, Zhou H, Hu M, Feng H. Effect of diet on insulin resistance in polycystic ovary syndrome. J Clin Endocrinol Metabol. 2020;105(10):3346-60.
Murri M, Luque-Ramírez M, Insenser M, Ojeda-Ojeda M, Escobar-Morreale HF. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Human Reprod Upd. 2013;19(3):268-88.
Lim SS, Davies MJ, Norman RJ, Moran LJ. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Human Reprod Upd. 2012;18(6):618-37.
Joshi B, Mukherjee S, Patil A, Purandare A, Chauhan S, Vaidya R. A cross-sectional study of polycystic ovarian syndrome among adolescent and young girls in Mumbai, India. Ind J Endocri Metabol 2014;18(3):317.
Tabassum F, Jyoti C, Sinha HH, Dhar K, Akhtar MS. Impact of polycystic ovary syndrome on quality of life of women in correlation to age, basal metabolic index, education and marriage. PloS one. 2021;16(3):e0247486.
Diamant YZ, Rimon E, Evron S. High incidence of preeclamptic toxemia in patients with polycystic ovarian disease. European Journal of Obstetrics & Gynecology and Reproductive Biology. 1982 Dec 1;14(3):199-204.
Teede HJ, Joham AE, Paul E, Moran LJ, Loxton D, Jolley D, et al. Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women. Obesity. 2013;21(8):1526-32.
Roya R, Mohammad Akbar A, Wajeeda T, Avinash B, Humaira M, Avvari BB, et al. An Indian evidence-based study of prevalence, phenotypic features, lifestyle modifications of polycystic ovarian syndrome patients. J Gynecol Wom Heal. 2021;21:556069.
Abdolahian S, Tehrani FR, Amiri M, Ghodsi D, Yarandi RB, Jafari M, et al. Effect of lifestyle modifications on anthropometric, clinical, and biochemical parameters in adolescent girls with polycystic ovary syndrome: a systematic review and meta-analysis. BMC Endocr Dis. 2020;20(1):1-7.
Thomson RL, Buckley JD, Brinkworth GD. Exercise for the treatment and management of overweight women with polycystic ovary syndrome: a review of the literature. Obesity Revi. 2011;12(5):e202-10.
Kulshreshtha B, Arora A, Pahuja I, Sharma N, Pant S. Menstrual cyclicity post OC withdrawal in PCOS: Use of non-hormonal options. J Obstet Gynaecol. 2016;36(6):833-8.
Moran LJ, Hutchison SK, Norman RJ, Teede HJ. Lifestyle changes in women with polycystic ovary syndrome. Coch Data System Revi. 2011;(7):Cd007506.
DeUgarte CM, Woods KS, Bartolucci AA, Azziz R. Degree of facial and body terminal hair growth in unselected black and white women: toward a populational definition of hirsutism. J Clin Endocrinol Metabol. 2006;91(4):1345-50.
Khoury MY, Baracat EC, Pardini DP, Haidar MA, Motta EL, Lima GR. Polycystic ovary syndrome: clinical and laboratory evaluation. Sao Paulo Med J. 1996;114:1222-5.
Orio Jr F, Matarese G, Di Biase S, Palomba S, Labella D, Sanna V, et al. Exon 6 and 2 peroxisome proliferator-activated receptor-γ polymorphisms in polycystic ovary syndrome. J Clin Endocrinol Metabol. 2003;88(12):5887-92.
Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. J Clin Endo Metabol. 2006;91(11):4237-45.
Coskun A, Ercan O, Arikan DC, Özer A, Kilinc M, Kiran G, et al. Modified Ferriman-Gallwey hirsutism score and androgen levels in Turkish women. Euro J Obstet Gynecol Reprod Biol. 2011;154(2):167-71.
Yang H, Di J, Pan J, Yu R, Teng Y, Cai Z, et al. The association between prolactin and metabolic parameters in PCOS women: a retrospective analysis. Front Endocrinol. 2020;11:263.
Sinha U, Sinharay K, Saha S, Longkumer TA, Baul SN, Pal SK. Thyroid disorders in polycystic ovarian syndrome subjects: A tertiary hospital based cross-sectional study from Eastern India. In J Endocrinol Metabol. 2013;17(2):304-9.
